Purchase of a platform high throughput metagenomics sequencing system

The contract pertains to the procurement of a new Aviti Element system intended for evaluation as a potential replacement for the current Illumina high throughput sequencing systems. This system will support critical technology assessments conducted by whole genome sequencing specialists focused on genomic food safety applications. Initially, the contract is established as an unfunded zero dollar requisition, with the possibility of funding and formal execution to be reconsidered in the summer of 2026. The contract is under the Food and Drug Administration and is categorized as a forecast for the purchase of a high throughput metagenomics sequencing platform. Key contacts include the acquisition liaison for program inquiries and a contracting officer role yet to be assigned. The effort falls under the NAICS code 334516, relating to electronic and precision equipment manufacturing. Location details and a solicitation number are not specified, reflecting the contract’s preliminary status until further funding decisions are made.